
Validea's guru fundamental report indicates BECTON DICKINSON AND CO (BDX) received a 54% rating using its P/E/Growth Investor model, based on Peter Lynch's strategy, which seeks stocks with reasonable price-to-earnings growth and strong balance sheets. While BDX passed criteria for P/E/Growth, inventory, and total debt/equity, it notably failed on sales and P/E ratio and EPS growth rate. This 54% score falls significantly below the 80% threshold typically indicating investor interest, suggesting BDX does not currently align strongly with this growth-oriented value strategy.
According to a Validea fundamental report, Becton Dickinson and Co. (BDX) scores a 54% based on a model replicating Peter Lynch's investment strategy, a figure well below the 80% threshold that typically indicates guru interest. The analysis reveals a mixed fundamental picture for the large-cap medical supplies company. On one hand, BDX passes on key Lynch criteria including its P/E/Growth ratio, inventory-to-sales management, and a healthy total debt/equity ratio, suggesting a reasonable valuation and a strong balance sheet. However, these strengths are offset by significant weaknesses, as the company fails on its sales and P/E ratio metric and, most critically for a growth-focused strategy, its EPS growth rate. Furthermore, its free cash flow and net cash position were rated as neutral, providing neither a compelling positive nor a negative signal. The low overall score is primarily driven by the failure to meet essential growth benchmarks, indicating that despite its stable financial structure, BDX does not currently align with the growth-at-a-reasonable-price (GARP) criteria of the Lynch model.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment